NCT07208604View on ClinicalTrials.gov

Open Label, Multi-center, Phase I Study of TECLens Quantitative Refractive Crosslinking in Presbyopia-Aged Patients.

NANot yet recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Presbyopia
Interventions
DEVICE

Quantitative refractive crosslinking

Non-invasive corneal cross-linking device delivering controlled UV light through a contact lens platform for biomechanical stabilization of the cornea.

Trial Locations (1)

Unknown

Asian Eye Institute, Makati City

All Listed Sponsors
collaborator

Robert Ang, MD

UNKNOWN

collaborator

Robert Ang, MD - Asian Eye Institute

UNKNOWN

lead

TECLens, Inc.

INDUSTRY

NCT07208604 - Open Label, Multi-center, Phase I Study of TECLens Quantitative Refractive Crosslinking in Presbyopia-Aged Patients. | Biotech Hunter | Biotech Hunter